Ginkgo Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer microbes to convert CO2 emissions into fuel and is somehow making yeast smell like roses. Bioworks co-founder Jason Kelly considers these projects, and many others, the future of the… Read More|
|
|
Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma
Ginkgo Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer microbes to convert CO2 emissions into fuel and is somehow making yeast smell like roses. Bioworks co-founder Jason Kelly considers these projects, and many others, the future of the… Read More